End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-27 pm EDT
|
5-day change
|
1st Jan Change
|
3.78
CNY
|
+2.16%
|
|
+2.72%
|
+10.53%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,950
|
2,329
|
2,147
|
2,511
|
2,787
|
1,778
|
Enterprise Value (EV)
1 |
1,719
|
2,231
|
2,539
|
3,476
|
4,027
|
2,650
|
P/E ratio
|
53.6
x
|
26.4
x
|
138
x
|
30.2
x
|
-21.4
x
|
-13.7
x
|
Yield
|
1.6%
|
2.23%
|
-
|
-
|
0.56%
|
-
|
Capitalization / Revenue
|
0.45
x
|
0.54
x
|
0.54
x
|
0.45
x
|
0.46
x
|
0.39
x
|
EV / Revenue
|
0.4
x
|
0.52
x
|
0.63
x
|
0.62
x
|
0.66
x
|
0.58
x
|
EV / EBITDA
|
13.2
x
|
14
x
|
43.4
x
|
15.7
x
|
32.8
x
|
14.7
x
|
EV / FCF
|
30.9
x
|
-12.2
x
|
-7.04
x
|
-8.11
x
|
13.2
x
|
6.45
x
|
FCF Yield
|
3.23%
|
-8.22%
|
-14.2%
|
-12.3%
|
7.57%
|
15.5%
|
Price to Book
|
2.27
x
|
2.47
x
|
2.36
x
|
2.42
x
|
3.17
x
|
2.44
x
|
Nbr of stocks (in thousands)
|
519,875
|
519,875
|
519,875
|
519,875
|
519,875
|
519,875
|
Reference price
2 |
3.750
|
4.480
|
4.130
|
4.830
|
5.360
|
3.420
|
Announcement Date
|
4/26/19
|
4/28/20
|
4/28/21
|
3/30/22
|
4/28/23
|
4/28/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
4,320
|
4,298
|
3,998
|
5,572
|
6,059
|
4,548
|
EBITDA
1 |
130
|
159.2
|
58.56
|
221.6
|
122.6
|
180.8
|
EBIT
1 |
68.77
|
92.25
|
-10.79
|
130.9
|
-104.6
|
-64.44
|
Operating Margin
|
1.59%
|
2.15%
|
-0.27%
|
2.35%
|
-1.73%
|
-1.42%
|
Earnings before Tax (EBT)
1 |
50.2
|
141.6
|
-6.493
|
117
|
-151.6
|
-116
|
Net income
1 |
37.25
|
90.77
|
14.55
|
82.06
|
-130.9
|
-127.8
|
Net margin
|
0.86%
|
2.11%
|
0.36%
|
1.47%
|
-2.16%
|
-2.81%
|
EPS
2 |
0.0700
|
0.1700
|
0.0300
|
0.1600
|
-0.2500
|
-0.2500
|
Free Cash Flow
1 |
55.59
|
-183.3
|
-360.4
|
-428.4
|
304.7
|
410.9
|
FCF margin
|
1.29%
|
-4.27%
|
-9.01%
|
-7.69%
|
5.03%
|
9.04%
|
FCF Conversion (EBITDA)
|
42.77%
|
-
|
-
|
-
|
248.58%
|
227.23%
|
FCF Conversion (Net income)
|
149.22%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0600
|
0.1000
|
-
|
-
|
0.0300
|
-
|
Announcement Date
|
4/26/19
|
4/28/20
|
4/28/21
|
3/30/22
|
4/28/23
|
4/28/24
|
Fiscal Period: December |
2021 S1
|
2023 Q2
|
---|
Net sales
|
-
|
-
|
EBITDA
|
-
|
-
|
EBIT
|
-
|
-
|
Operating Margin
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
1 |
24.79
|
-21.33
|
Net margin
|
-
|
-
|
EPS
2 |
0.0480
|
-0.0400
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
8/27/21
|
8/22/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
391
|
965
|
1,240
|
872
|
Net Cash position
1 |
230
|
97.9
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
6.686
x
|
4.354
x
|
10.12
x
|
4.82
x
|
Free Cash Flow
1 |
55.6
|
-183
|
-360
|
-428
|
305
|
411
|
ROE (net income / shareholders' equity)
|
4.16%
|
11.4%
|
-0.04%
|
7.73%
|
-11.5%
|
-11.5%
|
ROA (Net income/ Total Assets)
|
3.51%
|
4.2%
|
-0.39%
|
3.4%
|
-2.26%
|
-1.48%
|
Assets
1 |
1,061
|
2,159
|
-3,695
|
2,412
|
5,783
|
8,618
|
Book Value Per Share
2 |
1.650
|
1.810
|
1.750
|
1.990
|
1.690
|
1.400
|
Cash Flow per Share
2 |
0.4500
|
0.4400
|
0.3300
|
0.3700
|
0.3100
|
0.2600
|
Capex
1 |
58.9
|
143
|
570
|
290
|
169
|
127
|
Capex / Sales
|
1.36%
|
3.34%
|
14.26%
|
5.2%
|
2.79%
|
2.8%
|
Announcement Date
|
4/26/19
|
4/28/20
|
4/28/21
|
3/30/22
|
4/28/23
|
4/28/24
|
|
1st Jan change
|
Capi.
|
---|
| +10.53% | 266M | | +3.08% | 104B | | -10.06% | 61.03B | | +72.86% | 47.64B | | +17.31% | 39.24B | | +3.82% | 32.09B | | +13.58% | 20.39B | | +13.81% | 16.85B | | +11.47% | 14.28B | | -0.10% | 13.88B |
Other Commodity Chemicals
|